William Lis
2022 - Jasper Therapeutics
In 2022, William Lis earned a total compensation of $1M as Former Executive Chairman, Chief Executive Officer and President at Jasper Therapeutics, a 53% increase compared to previous year.
Compensation breakdown
| Option Awards | $343,266 |
|---|---|
| Salary | $110,417 |
| Stock Awards | $341,806 |
| Other | $242,111 |
| Total | $1,037,600 |
Lis received $343.3K in option awards, accounting for 33% of the total pay in 2022.
Lis also received $110.4K in salary, $341.8K in stock awards and $242.1K in other compensation.
Rankings
In 2022, William Lis' compensation ranked 2,942nd out of 5,736 executives tracked by ExecPay. In other words, Lis earned more than 48.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,942 out of 5,736 | 49th |
Division Manufacturing | 1,649 out of 3,125 | 47th |
Major group Chemicals And Allied Products | 772 out of 1,416 | 46th |
Industry group Drugs | 721 out of 1,317 | 45th |
Industry Biological Products, Except Diagnostic Substances | 173 out of 291 | 41st |
Source: SEC filing on April 21, 2023.
Lis' colleagues
We found three more compensation records of executives who worked with William Lis at Jasper Therapeutics in 2022.